Jump to content
PC Security Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE

Blogs

“China Pharmaceutical Contract Manufacturing Services Market, 2020-2030” <Roots Analysis>

Key Inclusions §  A review of the current market landscape of companies offering pharmaceutical contract manufacturing services in China, along with information on year of establishment, company size, location of headquarters, type of product (active pharmaceutical ingredients (APIs), intermediates and finished dosage formulations (FDFs)), type of FDFs, type of packaging and number of manufacturing facilities. §  A detailed landscape of the pharmaceutical manufacturing facilities in Ch

Presently, over 100 CMOs across the globe claim to have manufacturing facilities in China.

A growing economy, large population base, and innovation-friendly environment are other key parameters that are anticipated to drive the growth of the pharmaceutical contract manufacturing market in China. Further, in order to meet the growing demand for their services, CMOs having manufacturing facilities in China are actively expanding their existing capacities and capabilities in the region.   To order this 200+ page report, which features 85+ figures and 100+ tables, please visit t

The contract manufacturing market for Pharmaceuticals in China is projected to grow at an annualized rate of ~8.9% <till 2030>

Roots Analysis has done a detailed study on China Pharmaceutical Contract Manufacturing Services Market, 2020-2030.”, covering key aspects of the industry and identifying key future growth opportunities.   To order this 200+ page report, which features 85+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/china-pharmaceutical-contract-manufacturing/312.html   Key Market Insights §  Presently, over 100 CMOs across the globe

The contract manufacturing market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030 <Roots Analysis>

Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world   Roots Analysis is pleased to announce the publication of its recent study, titled, “China Pharmaceutical Contract Manufacturing Services Market, 2020-2030.”   The report features an extensive study of the current market landscape and future opportunit

“Endocannabinoid System Targeted Therapeutics Market, 2020-2030” <Roots Analysis>

To order this 250+ page report, which features 140+ figures and 170+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html   Key Inclusions §  A detailed assessment of the current market landscape of endocannabinoid system targeted therapeutics, providing information on phase of development (clinical, preclinical, and discovery stage) of lead candidates, target therapeutic area (s), route of administration (oral, topi

More than 65 industry players across the world are presently engaged in evaluating by Roots Analysis

Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredients that offer clinical benefit, minus the addictive properties of the crude substance. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of cannabinoids.   To order this 250+ page report, which features 140+ figures

Endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030 <Roots Analysis>

So far, more than 100 different cannabinoids have been identified, and there is a growing body of evidence supporting the clinical benefits of this class of compounds in treating the symptoms of a wide variety of chronic health conditions   Roots Analysis is pleased to announce the publication of its recent study, titled, “Endocannabinoid System Targeted Therapeutics Market, 2020-2030 “   The report features an extensive study of the current market landscape, offering an inf

The endocannabinoid system targeted therapeutics market growing at an annualized rate of 30%.

So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting <Roots Analysis>   London   Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to its list of offerings.   Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredi

‘Elastomeric Closure Components Market for Vials, Cartridges and Syringes, 2019-2030’

To order this detailed 400+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html   Key Inclusions §  A detailed assessment of the current market landscape of companies manufacturing elastomeric container closures, featuring information on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, a

There are over 240 closures, fabricated using a variety of elastomeric materials, available for use in parenteral primary packaging containers.

The materials used to fabricate pharmaceutical packaging components are extremely important to preserving the stability, efficacy and safety of drug formulations. In fact, according to the USFDA, in the last two years, there have been over 2,000 drug and device recalls owing to packaging-related concerns. Elastomeric closures, with various types of coatings (such as FluoroTec® and Teflon®), have emerged as a promising option for developing closures for pharmaceutical containers.   To o

The elastomeric closures market is growing at an annualized rate of 6.7%, claims <Roots Analysis>

Roots Analysis has done a detailed study on Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030.”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 400+ page report, which features 185+ figures and 235+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html   Ke

Elastomeric closures market is projected to reach USD 9.3 Billion by 2030 .

Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have developed container-closures systems using more versatile materials; in this context, elastomers have demonstrated significant potential   Roots Analysis is pleased to announce the publication of its recent study, titled, “Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030.”   The report features a comprehensive study of the current scenario an

“Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030” (based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic)

To order this detailed 500+ page report, please visit this -https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html   Key Inclusions §  A detailed assessment of the current market landscape featuring over 280 stem cell-based therapies approved / under clinical development, including information on drug / therapy developer(s) (such as year of establishment, company size and location of headquarters), phase of development (marketed, phase III, phase II, phase

Over 280 stem cell therapy products for the treatment of a variety of disease indications

There is a growing body of evidence supporting the vast applicability and superiority of treatment outcomes of stem cell therapies, compared to conventional treatment options. In fact, the unmet needs within this domain have spurred the establishment of many start-ups in recent years. Further, recent studies suggest that mesenchymal stem cells mesenchymal stem cells can be effectively used to improve patients' resistance to the SARS-CoV-2 virus induced pneumonia leading to speedy recovery.

The stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030.

Roots Analysis has done a detailed study on “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent))”covering key aspects of the industry’s evolution and

With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030 <claims Roots>

With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism. In fact, recent studies suggest that mesenchymal stem cells have the potential to end the Coronavirus (COVID-19) pandemic.   Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Stem Cells Market: Focus on Clinical T

‘‘Microbial Contract Biomanufacturing Market, 2020-2030’’ , Claim Roots

To order this detailed 320+ page report, please visit this - https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html   Key Inclusions §  A detailed review of the current landscape of companies offering contract manufacturing services for biologics, using microbial expression systems, along with information on their year of establishment, company size, location of headquarters, number and location of their production facilities, scale of operation (pre

Across the world, claim to offer a variety of product development, manufacturing and support services <claims Roots>

Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly. Presently, a number of service provider companies claim to offer end-to-end solutions, ranging from product development to commercial production, for microbial biologics. Given the obvious advantages of outsourcing, drug developers are likely to continue rely

The microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030 <predicts Roots>

Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs   Roots Analysis is pleased to announce the publication of its recent study, titled, “Microbial Contract Biomanufacturing Market, 2020-2030.   The report features an extensive study of the current market landscape and future opportunities

Microbial contract biomanufacturing market is growing at a CAGR of 8.7%, <claims Roots>

The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment     London   Roots Analysis has announced the addition of the “Microbial Contract Biomanufacturing Market, 2020-2030” report to its list of offerings.   Despite mammalian cell cultures being the preferred manufactur

“Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 “ *Roots Analysis*

To order this detailed 500+ page report, please visit this -https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html   Key Inclusions §  A detailed assessment of the current market landscape featuring over 280 stem cell-based therapies approved / under clinical development, including information on drug / therapy developer(s) (such as year of establishment, company size and location of headquarters), phase of development (marketed, phase III, phase II, phase

More than 120 industry players are engaged in evaluating the potential of over 280 stem cell therapy

There is a growing body of evidence supporting the vast applicability and superiority of treatment outcomes of stem cell therapies, compared to conventional treatment options. In fact, the unmet needs within this domain have spurred the establishment of many start-ups in recent years. Further, recent studies suggest that mesenchymal stem cells mesenchymal stem cells can be effectively used to improve patients' resistance to the SARS-CoV-2 virus induced pneumonia leading to speedy recovery.

The stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, * Roots Analysis*

Roots Analysis has done a detailed study on “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent))”covering key aspects of the industry’s evolution and
×
  • Create New...